Stock Research for CRIS

CRIS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CRIS Stock Chart & Research Data

The CRIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CRIS Due diligence Resources & Stock Charts

The CRIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CRIS Detailed Price Forecast - CNN Money CNN View CRIS Detailed Summary - Google Finance
Yahoo View CRIS Detailed Summary - Yahoo! Finance Zacks View CRIS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CRIS Trends & Analysis - Trade-Ideas Barrons View CRIS Major Holders - Barrons
NASDAQ View CRIS Call Transcripts - NASDAQ Seeking View CRIS Breaking News & Analysis - Seeking Alpha
Spotlight View CRIS Annual Report - CompanySpotlight.com OTC Report View CRIS OTC Short Report - OTCShortReport.com
TradeKing View CRIS Fundamentals - TradeKing Charts View CRIS SEC Filings - Bar Chart
WSJ View Historical Prices for CRIS - The WSJ Morningstar View Performance/Total Return for CRIS - Morningstar
MarketWatch View the Analyst Estimates for CRIS - MarketWatch CNBC View the Earnings History for CRIS - CNBC
StockMarketWatch View the CRIS Earnings - StockMarketWatch MacroAxis View CRIS Buy or Sell Recommendations - MacroAxis
Bullish View the CRIS Bullish Patterns - American Bulls Short Pains View CRIS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CRIS Stock Mentions - StockTwits PennyStocks View CRIS Stock Mentions - PennyStockTweets
Twitter View CRIS Stock Mentions - Twitter Invest Hub View CRIS Investment Forum News - Investor Hub
Yahoo View CRIS Stock Mentions - Yahoo! Message Board Seeking Alpha View CRIS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CRIS - SECform4.com Insider Cow View Insider Transactions for CRIS - Insider Cow
CNBC View CRIS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CRIS - OTC Markets
Yahoo View Insider Transactions for CRIS - Yahoo! Finance NASDAQ View Institutional Holdings for CRIS - NASDAQ


Stock Charts

FinViz View CRIS Stock Insight & Charts - FinViz.com StockCharts View CRIS Investment Charts - StockCharts.com
BarChart View CRIS Stock Overview & Charts - BarChart Trading View View CRIS User Generated Charts - Trading View




Latest Financial News for CRIS


Curis Announces Leadership Change
Posted on Monday September 24, 2018

LEXINGTON, Mass., Sept. 24, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced a change in leadership with the appointment of James E. Dentzer as President and Chief Executive Officer effective immediately. In addition, Mr. Dentzer will become a member of the Curis Board of Directors. Mr. Dentzer, who joined Curis in 2016, was promoted earlier this year to Chief Operating Officer to manage all functions outside of research and development, including business development, manufacturing, quality, human resources, finance, legal, IT, and investor and public relations.


Report: Developing Opportunities within Q2, Ormat Technologies, The Andersons, Comstock Resources, Freshpet, and Curis — Future Expectations, Projections Moving into 2018
Posted on Wednesday August 29, 2018

NEW YORK, Aug. 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Q2 ...


Curis to Present at the Baird 2018 Global Healthcare Conference
Posted on Tuesday August 28, 2018

LEXINGTON, Mass., Aug. 28, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company will present at the Baird 2018 Global Healthcare Conference on Wednesday, September 5 at 2:35-3:05 PM in Session III - Empire Ballroom B, Mezzanine Level of the InterContinental New York Barclay in New York. The presentation will be held using a fireside-chat format in which Ali Fattaey, Ph.D. President and Chief Executive Officer, will provide a brief overview of the Company's pipeline of drug candidates and business strategy, after which an equity analyst will moderate a question and answer session. A live webcast of the presentation will be available by visiting the investors section of Curis' website http://investors.curis.com/events-and-presentations.


Edited Transcript of CRIS earnings conference call or presentation 2-Aug-18 12:30pm GMT
Posted on Sunday August 05, 2018

Q2 2018 Curis Inc Earnings Call


Stock Market & Investing Books

Enter a stock symbol to view the stock details.